Cite

HARVARD Citation

    Sulica, R. et al. (2019). Clinical and hemodynamic benefit of macitentan and riociguat upfront combination in patients with pulmonary arterial hypertension. Pulmonary circulation. pp. 1-8. [Online]. 
  
Back to record